Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Director/PDMR Shareholding

26 May 2017 07:00

RNS Number : 2927G
Plant Health Care PLC
26 May 2017
 

26 May 2017

Plant Health Care plc

("Plant Health Care" or the "Company")

Director / PDMR Shareholdings

Plant Health Care (AIM: PHC) was notified that on 23 May 2017, Richard Webb, Executive Director of the Company, purchased a total of 106,530 ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") at a price of 30 pence per Ordinary Share. Following the purchase, Richard Webb is beneficially interested in 868,400 Ordinary Shares, representing approximately 0.59 per cent. of the Company's issued share capital.

PHC was further notified that on 23 May 2017, Joelle Jenny, the spouse of Richard Webb purchased a total of 80,825 Ordinary Shares at a price of 30 pence per Ordinary Share. Following the purchase, Joelle Jenny, is beneficially interested in 80,825 Ordinary Shares, representing approximately 0.05 per cent. of the Company's issued share capital

 

Plant Health Care plc

Chris Richards - Executive Chairman and Interim CEO

Jeffrey Hovey - Chief Financial Officer

 

 

+1 919 926 1600

Liberum - Nomad and Broker

Clayton Bush

Chris Clarke

 

+44 (0) 203 100 2000

 

Company website: www.planthealthcare.com

 

1.

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Dr. Richard H Webb

Joelle Jenny

2.

Reason for the Notification

a)

Position/status

Executive Director

Spouse of Executive Director, Richard Webb

b)

Initial notification/ Amendment

Initial notification

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Plant Health Care plc

Plant Health Care plc

b)

LEI

pending

pending

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 1 penny each

Ordinary Shares of 1 penny each

Identification code

GB00B01JC540

GB00B01JC540

b)

Nature of the transaction

Purchase of Ordinary shares

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Price

Volume

Price

Volume

£0.30

106,530

£0.30

80,825

d)

Aggregated information:

·Aggregated volume

·Price

Single transaction as in 4c) above

106,530

£0.30

Single transaction as in 4c) above

80,825

£0.30

e)

Date of the transaction

23 May 2017

23 May 2017

f)

Place of the transaction

XLON

XLON

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHSEIFMIFWSEDI
Date   Source Headline
1st Jun 200911:37 amRNSTotal Voting Rights
1st Jun 20097:00 amRNSEuropean Patent Granted for Harpin
28th May 20095:51 pmRNSAdditional Listing
28th May 20095:23 pmRNSSignificant Shareholding
28th May 20098:47 amRNSHolding(s) in Company
20th May 20099:30 amRNSAdditional Listing
19th May 20098:00 amRNSTest results
18th May 20093:47 pmRNSDirector/PDMR Shareholding
18th May 200910:44 amRNSAdditional Listing
13th May 20091:15 pmRNSDirector/PDMR Shareholding
12th May 200911:53 amRNSEGM Statement
30th Apr 200912:41 pmRNSDirector/PDMR Shareholding
24th Apr 200911:50 amRNSPlacing Announcement
16th Apr 20095:01 pmRNSAnnual Financial Report
15th Apr 20095:20 pmRNSAdditional Listing
2nd Apr 20095:47 pmRNSMonsanto Order
1st Apr 20093:40 pmRNSAdditional Listing
30th Mar 20097:00 amRNSDirector/PDMR Shareholding
24th Mar 200910:49 amRNSChange of Registered Office
24th Mar 20097:00 amRNSFinal Results
2nd Mar 200910:06 amRNSTotal Voting Rights
2nd Feb 200912:53 pmRNSTotal Voting Rights
2nd Feb 200911:01 amRNSBoard Appointment
28th Jan 20094:36 pmRNSPrice Monitoring Extension
28th Jan 20097:00 amRNSAdditional Listing
22nd Jan 20097:00 amRNSTrading Statement
15th Jan 20097:00 amRNSNew Appointments
5th Jan 20099:57 amRNSSignificant Shareholding
31st Dec 200811:19 amRNSTotal Voting Rights
19th Dec 20084:22 pmRNSHolding(s) in Company
18th Dec 20087:01 amRNSFurther re Myconate
18th Dec 20087:00 amRNSTermination of Agreement
16th Dec 20087:00 amRNSFinal Agreement with Monsanto
1st Dec 200810:02 amRNSTotal Voting Rights
26th Nov 20087:00 amRNSField Trials
18th Nov 200812:21 pmRNSAdditional Listing
31st Oct 20083:35 pmRNSTotal Voting Rights
30th Oct 20084:01 pmRNSBoard Appointment
20th Oct 200811:26 amRNSHolding(s) in Company
8th Oct 20081:05 pmRNSSignificant shareholding
2nd Oct 20087:52 amRNSField Trials
30th Sep 20088:00 amRNSTotal Voting Rights
25th Sep 20087:00 amRNSRe Scotts agreement
23rd Sep 20087:00 amRNSPreTect Field Trial Results
17th Sep 20087:00 amRNSAgreement with Bayer CropScience
15th Sep 20082:06 pmRNSPosting of Interim Results
9th Sep 20084:32 pmRNSDirector/PDMR Shareholding
8th Sep 20087:01 amRNSSupply Agreement
8th Sep 20087:00 amRNSInterim Results
1st Sep 200810:03 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.